IsoRay (ISR) Reports Q2 Loss, Misses Revenue Estimates IsoRay (ISR) delivered earnings and revenue surprises of -100% and 56.31%, respectively, for the quarter ended December 2022. Do the…
Perspective Therapeutics (formerly known as Isoray, Inc.) Announces Financial Results for the Quarter ended December 31, 2022 Fiscal Calendar Year Changes from June to December Year End Fiscal Calendar Year Changes from June to December Year End...…
Isoray Inc. and Viewpoint Molecular Targeting Inc. Announce Name Change to Perspective Therapeutics Inc. Companys focus is on the advancement of cancer treatments using radiation, radiopharmaceuticals, and imaging technologies...…
Form 8-K Isoray, Inc. For: Jan 31 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Isoray, Inc. For: Jan 27 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Isoray Announces Results of Fiscal 2023 Annual Meeting of Stockholders Stockholders Approve Proposal One Clearing Way for Consummation of Merger Stockholders Approve Proposal One Clearing Way for Consummation of Merger...…
Form 8-K Isoray, Inc. For: Jan 12 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Isoray Announces Adjournment of Annual Meeting of Stockholders to January 27, 2023 RICHLAND, Wash., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and…
AMENDED: Isoray Announces Adjournment of Annual Meeting of Stockholders to January 12, 2023 RICHLAND, Wash., Dec. 14, 2022 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and…
Form 8-K Isoray, Inc. For: Dec 12 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Form 8-K Isoray, Inc. For: Nov 22 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Isoray To Announce First Quarter Fiscal 2023 Financial Results on November 10, 2022 Conference Call is Thursday, November 10, 2022 at 4:30 p.m. ET/1:30 p.m. PT Conference Call is Thursday, November 10, 2022…
STOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Isoray, Inc. - ISR NEW YORK, Oct. 27, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde &…
Form 8-K Isoray, Inc. For: Oct 21 Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…